JP2022539579A5 - - Google Patents

Info

Publication number
JP2022539579A5
JP2022539579A5 JP2021578216A JP2021578216A JP2022539579A5 JP 2022539579 A5 JP2022539579 A5 JP 2022539579A5 JP 2021578216 A JP2021578216 A JP 2021578216A JP 2021578216 A JP2021578216 A JP 2021578216A JP 2022539579 A5 JP2022539579 A5 JP 2022539579A5
Authority
JP
Japan
Application number
JP2021578216A
Other languages
Japanese (ja)
Other versions
JP2022539579A (ja
JPWO2021194318A5 (https=
JP7440940B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2021/003807 external-priority patent/WO2021194318A1/en
Publication of JP2022539579A publication Critical patent/JP2022539579A/ja
Publication of JPWO2021194318A5 publication Critical patent/JPWO2021194318A5/ja
Publication of JP2022539579A5 publication Critical patent/JP2022539579A5/ja
Priority to JP2023177565A priority Critical patent/JP2023171659A/ja
Application granted granted Critical
Publication of JP7440940B2 publication Critical patent/JP7440940B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021578216A 2020-03-27 2021-03-27 Plk1の選択的分解誘導化合物 Active JP7440940B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023177565A JP2023171659A (ja) 2020-03-27 2023-10-13 Plk1の選択的分解誘導化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2020-0037875 2020-03-27
KR20200037875 2020-03-27
PCT/KR2021/003807 WO2021194318A1 (en) 2020-03-27 2021-03-27 Plk1 selective degradation inducing compound

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023177565A Division JP2023171659A (ja) 2020-03-27 2023-10-13 Plk1の選択的分解誘導化合物

Publications (4)

Publication Number Publication Date
JP2022539579A JP2022539579A (ja) 2022-09-12
JPWO2021194318A5 JPWO2021194318A5 (https=) 2023-03-29
JP2022539579A5 true JP2022539579A5 (https=) 2023-03-29
JP7440940B2 JP7440940B2 (ja) 2024-02-29

Family

ID=77892014

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021578216A Active JP7440940B2 (ja) 2020-03-27 2021-03-27 Plk1の選択的分解誘導化合物
JP2023177565A Pending JP2023171659A (ja) 2020-03-27 2023-10-13 Plk1の選択的分解誘導化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023177565A Pending JP2023171659A (ja) 2020-03-27 2023-10-13 Plk1の選択的分解誘導化合物

Country Status (6)

Country Link
US (5) US20230158158A1 (https=)
EP (1) EP3911654A4 (https=)
JP (2) JP7440940B2 (https=)
KR (8) KR20210122165A (https=)
CN (1) CN113784969A (https=)
WO (4) WO2021194318A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020356484A1 (en) * 2019-09-27 2022-03-17 Dana-Farber Cancer Institute, Inc. ERK5 degraders as therapeutics in cancer and inflammatory diseases
US20230158158A1 (en) * 2020-03-27 2023-05-25 Uppthera Pyrazolo quinazoline derivative compounds inducing selective degradation of plk1
KR20240035820A (ko) 2021-07-09 2024-03-18 플렉시움 인코포레이티드 Ikzf2를 조절하는 아릴 화합물 및 약학 조성물
EP4157849A4 (en) * 2021-08-10 2024-12-11 Uppthera, Inc. NOVEL PLK1 DEGRADATION-INDUCING COMPOUND
US20250171417A1 (en) 2021-08-11 2025-05-29 Xizang Haisco Pharmaceutical Co., Ltd. Heterocyclic derivative, and composition and pharmaceutical use thereof
CN114380682A (zh) * 2021-10-27 2022-04-22 上海毕得医药科技股份有限公司 一种2,3-二氟-4-甲氧基苯乙酸合成方法
CN118339161B (zh) * 2021-12-10 2025-12-09 正大天晴药业集团股份有限公司 一种异噻唑并[5,4-d]嘧啶类IRAK4抑制剂的制备方法
CN118382626A (zh) * 2021-12-10 2024-07-23 山东绿叶制药有限公司 蛋白激酶抑制剂及其制备方法和应用
CN116924929A (zh) * 2022-07-08 2023-10-24 重庆圣华曦药业股份有限公司 一种碘比醇异构体的合成方法
CN115490675B (zh) * 2022-09-19 2024-11-12 安阳师范学院 季酮酸衍生物及其制备方法与应用
CN120603831A (zh) * 2022-11-29 2025-09-05 厄普特拉株式会社 具有增加的刚性的plk1降解诱导化合物
CN120530121A (zh) * 2023-01-17 2025-08-22 北京哲源科技有限责任公司 吡唑并喹唑啉类化合物的立体异构体和氘代衍生物及应用
KR20250037591A (ko) * 2023-02-02 2025-03-17 (주) 업테라 신규 plk1 분해 유도 화합물
CN116554044A (zh) * 2023-05-16 2023-08-08 上海师范大学 一种无氨基保护的2,6-二异丙基-4-羧基苯胺及其合成方法
KR20250058831A (ko) 2023-10-23 2025-05-02 주식회사 펩토이드 Plk-1의 폴로박스 도메인에 결합하는 저분자 화합물을 함유하는 항암제
WO2025239662A1 (ko) * 2024-05-13 2025-11-20 (주) 업테라 분해 약물-항체 접합체용 plk1 분해 유도 화합물
CN119707950A (zh) * 2024-12-24 2025-03-28 无锡市南京大学锡山应用生物技术研究所 一种用于免疫蛋白靶向降解的嵌合体及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1937671E (pt) * 2005-09-06 2010-03-12 Smithkline Beecham Corp Compostos de benzimidazole tiofeno como inibidores de plk
PT2125822E (pt) * 2006-12-21 2015-01-30 Nerviano Medical Sciences Srl Derivados de pirazol-quinazolina substituídos, processo para sua preparação e seu uso como inibidores da quinase
WO2008113711A1 (en) * 2007-03-22 2008-09-25 F. Hoffmann-La Roche Ag Substituted pyrimidodiazepines useful as plk1 inhibitors
WO2009042711A1 (en) * 2007-09-25 2009-04-02 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
JP2011527667A (ja) 2008-06-18 2011-11-04 武田薬品工業株式会社 ハロ置換ピリミドジアゼピン
AR076784A1 (es) * 2009-05-26 2011-07-06 Nerviano Medical Sciences Srl Combinacion terapeutica que comprende un inhibidor de plk1 y un agente antineoplasico
CA2861066C (en) * 2012-01-12 2024-01-02 Yale University Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an e3 ubiquitin ligase
AU2015247817C1 (en) 2014-04-14 2022-02-10 Arvinas Operations, Inc. Imide-based modulators of proteolysis and associated methods of use
US10730870B2 (en) 2015-03-18 2020-08-04 Arvinas Operations, Inc. Compounds and methods for the enhanced degradation of targeted proteins
WO2016197114A1 (en) 2015-06-05 2016-12-08 Arvinas, Inc. Tank-binding kinase-1 protacs and associated methods of use
AU2016349781A1 (en) * 2015-11-02 2018-05-10 Yale University Proteolysis targeting chimera compounds and methods of preparing and using same
US20170281784A1 (en) 2016-04-05 2017-10-05 Arvinas, Inc. Protein-protein interaction inducing technology
CN106543185B (zh) 2016-11-10 2017-12-15 吉林大学 一种靶向泛素化降解plk1和brd4蛋白的化合物及其应用
BR112019015484A2 (pt) * 2017-01-31 2020-04-28 Arvinas Operations Inc ligantes de cereblon e compostos bifuncionais compreendendo os mesmos
CN106977584B (zh) * 2017-04-19 2019-12-06 吉林大学 靶向泛素化降解plk1和brd4蛋白的化合物及其应用
CN109912655B (zh) 2017-12-13 2021-12-10 上海科技大学 Alk蛋白降解剂及其抗肿瘤应用
KR102127289B1 (ko) * 2018-09-18 2020-06-26 고려대학교 산학협력단 암 세포를 표적화하기 위한 plk 선택적 형광 프로브 화합물 및 이를 포함하는 plk 검출용 형광 센서
CN111018857B (zh) * 2018-10-09 2023-06-02 嘉兴优博生物技术有限公司 靶向蛋白酶降解平台(ted)
CN109879877B (zh) 2019-03-04 2021-08-10 吉林大学 一种可降解plk1和brd4蛋白的化合物及其应用
US20230158158A1 (en) * 2020-03-27 2023-05-25 Uppthera Pyrazolo quinazoline derivative compounds inducing selective degradation of plk1
EP4157849A4 (en) * 2021-08-10 2024-12-11 Uppthera, Inc. NOVEL PLK1 DEGRADATION-INDUCING COMPOUND

Similar Documents

Publication Publication Date Title
BR112023012656A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112023011738A2 (https=)
BR112023006729A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)
BR102021016200A2 (https=)
BR102021015566A2 (https=)
BR102021015450A8 (https=)
BR102021015220A2 (https=)
BR102021015247A2 (https=)
BR102021014056A2 (https=)
BR102021014044A2 (https=)
BR102021013929A2 (https=)
BR102021012571A2 (https=)